Zocere Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zocere Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11325
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zocere Inc (Zocere), formerly Tyrosine Pharmaceuticals Inc is a biotechnology company that develops novel therapeutics for neurological diseases. The company offers services to support the pharmaceutical and biotechnology fields developing stroke-related diagnostics and treatments. Its drugs are designed to protect patients from brain injury by arresting the progression of neurological damage caused by reduced blood flow. Zocere holds expertise in drug research and clinical development; pre-commercialization; and niche product development services, among others. The company develops licensed patented technology for a derivative of the brain-specific STEP protein, tyrosine phosphatase, and injectable neuroprotectant drugs. Zocere is headquartered in Albuquerque, New Mexico, the US.

Zocere Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zocere Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zocere Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zocere Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Zocere to Raise USD3 Million in Venture Financing 10
Tyrosine Pharma To Raise US$0.25 Million In Venture Financing 11
Zocere Raises USD0.1 Million in Venture Financing 12
Licensing Agreements 13
Zocere Enters Into Licensing Agreement With STC.UNM For Stroke And Other Brain Trauma 13
Zocere Inc – Key Competitors 14
Zocere Inc – Key Employees 15
Zocere Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Zocere Inc, Pharmaceuticals & Healthcare, Key Facts 2
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zocere Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zocere Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Zocere Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zocere to Raise USD3 Million in Venture Financing 10
Tyrosine Pharma To Raise US$0.25 Million In Venture Financing 11
Zocere Raises USD0.1 Million in Venture Financing 12
Zocere Enters Into Licensing Agreement With STC.UNM For Stroke And Other Brain Trauma 13
Zocere Inc, Key Competitors 14
Zocere Inc, Key Employees 15

List of Figures
Zocere Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zocere Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zocere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Zocere Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Envipco Holding NV (ENVI):企業の財務・戦略的SWOT分析
    Envipco Holding NV (ENVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Beaver Aerospace & Defense, Inc.:企業の戦略・SWOT・財務情報
    Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Canon Marketing Japan Inc (8060):企業の財務・戦略的SWOT分析
    Canon Marketing Japan Inc (8060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sumitomo Corp (8053):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • Top Image Systems Ltd (TISA):企業の戦略的SWOT分析
    Top Image Systems Ltd (TISA) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Japan Airlines Co Ltd:企業のM&A・事業提携・投資動向
    Japan Airlines Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Japan Airlines Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • SurgaColl Technologies Ltd:製品パイプライン分析
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops regenerative technologies. The company’s products comprise hydroxycoll and chondrocoll. It offers regenerative solutions in the field of bone, cartilage and osteochondral tissue regeneration. SurgaC …
  • Presidio Inc (PSDO):企業の財務・戦略的SWOT分析
    Presidio Inc (PSDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ALFA, S.A.B. de C.V.:企業の戦略・SWOT・財務分析
    ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • World Fuel Services Corporation:企業の戦略・SWOT・財務情報
    World Fuel Services Corporation - Strategy, SWOT and Corporate Finance Report Summary World Fuel Services Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Vectra Bank Colorado:企業の戦略・SWOT・財務情報
    Vectra Bank Colorado - Strategy, SWOT and Corporate Finance Report Summary Vectra Bank Colorado - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Danaher Corp (DHR):医療機器:M&Aディール及び事業提携情報
    Summary Danaher Corp (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. It offers a wide range of testing instruments, communications solutions, water quality systems, medical diagnostics solutions …
  • Euronav NV (EURN):企業の財務・戦略的SWOT分析
    Summary Euronav NV (Euronav) is a transportation and logistics company that offers shipping services. The company provides sea-borne transportation, tanker shipping, proactive management, fleet composition and ship management services, among others. It offers ship management services which includes …
  • DHL International GmbH:企業の戦略的SWOT分析
    DHL International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NorthWestern Corporation (NWE):電力:M&Aディール及び事業提携情報
    Summary NorthWestern Corporation, doing business as NorthWestern Energy, is an electric and natural gas utility. It generates, transmits, and electricity, and also carries out mid-stream operations. The company produces from wind, hydro, solar, coal, and natural gas. NorthWestern Energy produces, st …
  • Owens & Minor Inc (OMI):企業の財務・戦略的SWOT分析
    Owens & Minor Inc (OMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Oil and Natural Gas Corporation Limited:企業の戦略・SWOT・財務分析
    Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Celsia SA ESP (CELSIA):電力:M&Aディール及び事業提携情報
    Summary Celsia SA ESP (Celsia), formerly Compania Colombiana de Inversiones SA ESP, a subsidiary of Grupo Argos SA, is an energy company that generates, transmits, distributes, and sells electricity. The company’s product categories include home line, solar energy, backup energy, thermal network, ef …
  • Ryder System, Inc.:企業の戦略・SWOT・財務情報
    Ryder System, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ryder System, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PharmaEngine Inc (4162):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaEngine Inc (PharmaEngine) is a biopharmaceutical company that discovers and develops cancer treatment drugs and related medicinal products. The company develops drugs for the treatment of cancer and Asian prevalent diseases. Its products include Onivyde a liposome encapsulation of irin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆